Cryptocurrencies
How Ozempic, weight-loss drugs force health enthusiasts to change
The GLP-1 drugs originally manufactured for type 2 diabetes patients continue to gain popularity for their weight-loss side effects. Pharmaceutical companies Novo Nordisk (NVO) and Eli Lilly (LLY) are leading the way with medicines approved Read more…